Gilla Kaplan

Gilla Kaplan is currently Chairman at Desmond Tutu Hiv Foundation, Independent Director at Avalo Therapeutics, Inc. since 2020, and Venture Advisor at Israel Biotech Fund.
Former positions include Independent Director at Celgene Corp.
from 2011 to 2018, Director at MGI PHARMA, Inc., Director-Global Health Program at Gates Foundation Trust from 2014 to 2018, Assistant Director & Professor at the University of Medicine & Dentistry of New Jersey from 2011 to 2013, Assistant Director at Public Health Research Institute Center, Independent Director at Tyra Biosciences, Inc. from 2019 to 2026, Associate Professor at The Rockefeller University.
Education includes undergraduate studies at The Hebrew University of Jerusalem and graduate and doctorate degrees from the University of Tromso.